Showing results (1291-1300 of 1,365) with videos related to
Sort By:
Pageof 137
Journal of Medicinal Chemistry|October 27, 2012
Aminopiperidine sulfonamide Cav2.2 channel inhibitors for the treatment of chronic painPengcheng P Shao, Feng Ye, Prasun K Chakravarty, et al.Therapeutic Advances in Medical Oncology|August 2, 2024
A pooled analysis of clinical outcome in driver-gene negative non-small cell lung cancer patients with MET overexpression treated with gumarontinibYongfeng Yu, Wen Dong, Yanxia Shi, et al.The Journal of Infection|March 15, 2025
Oral ADC189 for adults and adolescents with uncomplicated influenzaJingya Zhao, Guoping Sheng, Yingqi Lyu, et al.Kidney International Supplements|May 13, 2021
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Western EuropeDearbhla M Kelly, Hans-Joachim Anders, Aminu K Bello, et al.Cell Host & Microbe|March 21, 2026
Human monoclonal antibodies isolated after seasonal vaccination broadly neutralize antigenically drifted influenza B virusesXiaoyu Cai, Miao Fan, Yanmei Zhai, et al.Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|May 16, 2024
Efficacy and safety of margetuximab plus chemotherapy <i>vs.</i> trastuzumab plus chemotherapy in Chinese patients with pretreated HER2-positive advanced metastatic breast cancer: results from a randomized, open-label, multicenter, phase II bridging studyQingyuan Zhang, Quchang Ouyang, Wei Li, et al.Journal of Hepatology|April 6, 2025
Cisplatin-induced disruption of mitochondrial divisome leads to enhanced cisplatin resistance in cholangiocarcinomaGuo-Yue Lv, Wen-Tao Mu, Yan-Nan Cao, et al.The Lancet. Respiratory Medicine|July 19, 2021
Icotinib versus chemotherapy as adjuvant treatment for stage II-IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trialJianxing He, Chunxia Su, Wenhua Liang, et al.Nature Medicine|February 1, 2024
First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 studyJin Li, Zhendong Chen, Yuxian Bai, et al.Cell Discovery|April 14, 2021
Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patientsHuanzi Zhong, Yanqun Wang, Zhun Shi, et al.Pageof 137